NASDAQ:IKT | Insider Transactions | Inhibikase Therapeutics, Inc.

IKT Insider Transactions

15 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 1–15; provenance stays internal.

IKT insiders transaction timeline

PurchaseSale
2021-11-17: 5 purchases — Werner Milton H.2022-05-19: 1 purchase — FRATTAROLI JOSEPH2022-05-20: 1 purchase — Werner Milton H.2022-05-27: 1 purchase — Werner Milton H.2022-08-16: 1 purchase — Werner Milton H.2024-10-21: 3 purchases — Bellini Roberto, Kush Arvind, Munshi Amit2025-11-21: 3 purchases — Sands Capital Alternatives, LLC, SANDS FRANK M., Sands Capital Life Sciences Pulse Fund II, L.P.2021-11-172025-11-21
Insider profileRoleDateTransactionSharesPrice
Sands Capital Alternatives, LLCTenPercentOwner2025-11-21Purchase2,068,965.0$1.45
SANDS FRANK M.TenPercentOwner2025-11-21Purchase2,068,965.0$1.45
Sands Capital Life Sciences Pulse Fund II, L.P.TenPercentOwner2025-11-21Purchase2,068,965.0$1.45
Bellini RobertoDirector2024-10-21Purchase1,460,000.0$1.37
Kush ArvindDirector2024-10-21Purchase145,000.0$1.37
Munshi AmitDirector2024-10-21Purchase365,000.0$1.37
Werner Milton H.President and CEO2022-08-16Purchase5,000.0$0.8
Werner Milton H.President and CEO2022-05-27Purchase5,000.0$0.98
Werner Milton H.President and CEO2022-05-20Purchase10,000.0$0.6
FRATTAROLI JOSEPHChief Financial Officer2022-05-19Purchase3,948.0$0.64
Werner Milton H.President and CEO2021-11-17Purchase400.0$1.93
Werner Milton H.President and CEO2021-11-17Purchase1,334.0$1.94
Werner Milton H.President and CEO2021-11-17Purchase3,186.0$1.96
Werner Milton H.President and CEO2021-11-17Purchase1,100.0$1.97
Werner Milton H.President and CEO2021-11-17Purchase17,569.0$1.98